Zobrazeno 1 - 10
of 150
pro vyhledávání: '"M. A. Ibragimova"'
Publikováno v:
Успехи молекулярной онкологии, Vol 11, Iss 2, Pp 116-129 (2024)
Introduction. It has been established that the presence of homologous recombination deficiency in a breast tumor is associated with the effectiveness of treatment. But despite the high chemosensitivity of the tumor to DNA-damaging agents, complete pa
Externí odkaz:
https://doaj.org/article/f002c3a047694a818f480db8fa6bfe71
Autor:
A. A. Rumyantsev, A. E. Protasova, M. Yu. Sheremet, A. Yu. Goryainova, M. V. Volkonskiy, A. G. Kedrova, S. V. Kuzmicheva, O. N. Aymamedova, Kh. S. Musaeva, S. M. Soroka, O. V. Romanchuk, V. N. Orlova, N. G. Graft, M. R. Ibragimova, Yu. I. Merzlikina, L. V. Stepura, L. B. Tatulova, A. A. Abasova, A. A. Akopyan, E. V. Arsenyeva, Yu. V. Vasilyeva, A. V. Belonogov, L. V. Krivolapova, A. A. Bobryshev, D. Yu. Vovk, I. A. Luev, N. R. Abidova, R. S. Zhikhorev, T. A. Zhelezkova, T. T. Grigoryan, T. A. Makarkina, V. A. Ekimov, A. V. Zhizhina, E. V. Karabina, O. A. Kuchevskaya, V. M. Filippova, T. A. Linchenko, A. A. Lisaeva, A. N. Fedorova, K. S. Maystrenko, E. V. Markizova, E. V. Kogay, E. P. Krasnorutskaya, M. E. Popova, Yu. Yu. Pchelin, R. A. Ryanzhina, D. B. Sidorov, E. B. Shakhnovich, S. M. Alekseev, M. V. Zinkevich, I. O. Belogortsev, V. A. Chubenko, V. M. Moiseenko, N. Kh. Abduloeva, A. A. Lebedinets, L. V. Strakh, L. K. Semenov, M. B. Bolieva, F. Z. Aydaeva
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 4, Pp 104-113 (2024)
Aim. To assess the efficacy and safety of lenvatinib and pembrolizumab for the treatment of mismatch repair-proficient endometrial cancer (EC) in routine clinical practice in Russia.Materials and methods. This multicenter, retrospective, cohort study
Externí odkaz:
https://doaj.org/article/b505b127d35446839d80501e03b80b14
Publikováno v:
Acta Biomedica Scientifica, Vol 8, Iss 3, Pp 42-54 (2023)
Every year, 570,000 new cases of cervical cancer (CC) are diagnosed in the world, and 311,000 people die from this disease. CC is the fourth most common type of cancer and therefore the fourth leading cause of cancer death in women worldwide. Numerou
Externí odkaz:
https://doaj.org/article/ad91d28db7c94ad9bab2f87accba25e4
Autor:
V. A. Markovich, S. A. Tuzikov, E. O. Rodionov, N. O. Popova, M. M. Tsyganov, S. V. Miller, D. V. Podolko, I. A. Tsydenova, M. K. Ibragimova, N. V. Litviakov
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 1, Pp 24-34 (2023)
Peritoneal carcinomatosis is associated with poor prognosis in gastric cancer patients. Stage IV gastric cancer (GC) is diagnosed in 39.8 % of patients; local metastases without evidence of distant metastases occur only in 18–20 % of stage IV gastr
Externí odkaz:
https://doaj.org/article/375ce25ce9ed4f46894b171b5b33e323
Autor:
K. V. Nevskaya, L. V. Efimova, P. V. Korda, D. S. Dolgasheva, M. K. Ibragimova, M. E. Menyailo, E. V. Udut, N. V. Litviakov, A. G. Pershina
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 6, Pp 59-67 (2023)
The aim of the study was mammosphere assay optimization for quantifcation of IL6-induced stemness in differentiated (СD44– ) T47D breast cancer cells.Material and Methods. The effect of three commonly used cell-detaching methods (TrypLE, accutase,
Externí odkaz:
https://doaj.org/article/9f072065bc7f44e98f6df083750603d4
Autor:
M. M. Tsyganov, M. K. Ibragimova, E. Yu. Garbukov, O. D. Bragina, E. A. Zdereva, E. A. Usynin, N. V. Litviakov
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 5, Pp 34-43 (2022)
ABC-transporter family genes have been well studied and their involvement in the development of drug resistance has been assessed. The presence of aberrant conditions in these genes can affect the treatment and prognosis of the disease. Loss of heter
Externí odkaz:
https://doaj.org/article/b1f0d2902e8542369a6b0f4f9d059ac9
Autor:
M. M. Tsyganov, M. K. Ibragimova, E. O. Rodionov, A. A. Frolova, S. V. Miller, O. V. Cheremisina, S. A. Tuzikov, N. V. Litvyakov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 4, Pp 253-260 (2022)
Introduction. To date, one of the reasons for the ineffectiveness of chemotherapy in various malignant neoplasms, including lung cancer, is the formation of the multidrug resistance (MDR) phenotype in tumor cells, which is caused by the expression of
Externí odkaz:
https://doaj.org/article/73391dd88ebb4b658f110b95736eddc9
Publikováno v:
Успехи молекулярной онкологии, Vol 9, Iss 1, Pp 33-41 (2022)
Introduction. Treatment of breast cancer often includes systemic neoadjuvant chemotherapy. The frequency of complete morphological response varies significantly depending on the molecular subtype of tumor. However, even in triple negative breast canc
Externí odkaz:
https://doaj.org/article/42cb627cd18e42b9aa11fc4d5c982475
Autor:
V. A. Markovich, S. A. Tuzikov, E. O. Rodionov, N. V. Litvyakov, N. O. Popova, M. M. Tsyganov, L. V. Levonyan, S. V. Miller, D. V. Podolko, I. A. Tsydenova, M. K. Ibragimova
Publikováno v:
Сибирский онкологический журнал, Vol 20, Iss 6, Pp 104-113 (2022)
Gastric cancer (gc) is one of the most common cancers worldwide. The majority of newly diagnosed gastric cancer cases present with distant metastases. Peritoneal carcinomatosis (pc) is the most unfavorable type of progression of primary gc, which occ
Externí odkaz:
https://doaj.org/article/7aac9b8edd454d76b77d06e24ec423ee
Autor:
K. A. Gaptulbarova, M. M. Tsyganov, M. K. Ibragimova, A. M. Pevzner, L. V. Spirina, N. V. Litviakov
Publikováno v:
Успехи молекулярной онкологии, Vol 8, Iss 4, Pp 8-20 (2021)
It is known that the immune system plays one of the main roles in the development of oncology. This is confirmed by the fact that patients with congenital or acquired immunodeficiency have a higher risk of developing cancer. To date, there are severa
Externí odkaz:
https://doaj.org/article/7e6e51dcb8194e16803c2cbc760a09e3